Biotech Hunter
Biotech Hunter
Home
Companies
Trials
People
Search
Home
/
Trials
/
NCT00343174
NCT00343174
View on ClinicalTrials.gov
Intravenous Ancrod for the Treatment of Acute Ischemic Stroke Within 6 Hours After Onset of Symptoms
PHASE3
Completed
INTERVENTIONAL
Timeline
Start Date
Not specified
Conditions
Brain Infarction
Cerebral Ischemia
Acute Stroke
Interventions
DRUG
Ancrod
All Listed Sponsors
lead
Heidelberg University
OTHER